Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Contrast Media Mol Imaging. 2014 Jan;9(1):37–52. doi: 10.1002/cmmi.1551

Figure 7.

Figure 7

A) Schematic depiction of the structure of a micelle-based, targeted bismuth core nanoparticle. B) Biodistribution of targeted and non-targeted nanoparticle formulations at 24 hours post-injection. T=tumor, Sp=spleen, Li=liver, K=kidney, Lu=lungs, H = heart, Br = brain, M = muscle. CT images acquired C) immediately and D) 24 hours post-injection of targeted nanoparticles. Figure adapted with permission from (48).